Ascendis Pharma ADR (ASND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -409,125 | -373,441 | -258,903 | -142,265 | -521,070 |
| Depreciation Amortization | 19,168 | 14,558 | 9,547 | 4,861 | 20,467 |
| Accounts receivable | -128,345 | 6,808 | -24,496 | -12,253 | -35,470 |
| Accounts payable and accrued liabilities | 29,179 | -19,824 | -11,384 | -20,655 | 3,843 |
| Other Working Capital | -115,955 | 7,907 | -2,459 | -56,282 | -107,998 |
| Other Operating Activity | 273,741 | 123,156 | 112,279 | 116,307 | 134,403 |
| Operating Cash Flow | $-331,336 | $-240,836 | $-175,416 | $-110,288 | $-505,825 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 7,957 | 8,087 | 7,920 | 7,984 | 312,639 |
| PPE Investments | -516 | -103 | 441 | -216 | -2,588 |
| Investing Cash Flow | $7,441 | $7,983 | $8,360 | $7,768 | $310,051 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 145,172 | 147,520 | N/A | -3,025 | 147,470 |
| Debt Repayment | -12,298 | -9,256 | -6,037 | N/A | N/A |
| Common Stock Issued | 368,376 | 349,785 | 23,233 | 23,027 | 11,133 |
| Other Financing Activity | -20,875 | 0 | 0 | 0 | -13,258 |
| Financing Cash Flow | $480,376 | $488,049 | $17,196 | $20,002 | $145,344 |
| Exchange Rate Effect | 24,641 | 1,397 | 6,129 | 4,429 | -6,503 |
| Beginning Cash Position | 424,361 | 431,224 | 422,321 | 425,773 | 481,371 |
| End Cash Position | 605,482 | 687,816 | 278,590 | 347,684 | 424,439 |
| Net Cash Flow | $181,121 | $256,593 | $-143,732 | $-78,089 | $-56,932 |
| Free Cash Flow | |||||
| Operating Cash Flow | -331,336 | -240,836 | -175,416 | -110,288 | -505,825 |
| Capital Expenditure | -1,544 | -1,148 | -583 | -216 | -2,643 |
| Free Cash Flow | -332,880 | -241,984 | -175,999 | -110,504 | -508,468 |